| Dennis Lee Doke, LMFT-S, LPC-S | |
|
9128 Autumn Falls Dr, Fort Worth, TX 76118-7765 | |
| (214) 677-6689 | |
| Not Available |
| Full Name | Dennis Lee Doke |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 9128 Autumn Falls Dr, Fort Worth, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194495549 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 1834 (Texas) | Primary |
| 101YP2500X | Counselor - Professional | 9709 (Texas) | Secondary |
| Entity Name | Sondermind Provider Network Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760854442 PECOS PAC ID: 9537572490 Enrollment ID: O20210326001541 |
News Archive
BioImagene, the leading provider of innovative digital pathology solutions, today announced the availability of the next generation of its digital pathology solution, VirtuosoTM. A highlight in this version is the ability to share cases in real time, allowing pathologists to collaborate with each other to sign out cases. Virtuoso users can participate in peer reviews, perform second-opinions for difficult cases, and guide residents in the review of cases for education.
Pfenex Inc., an industry leader in protein expression through the Pfenex Expression Technology platform and Boehringer Ingelheim International GmbH, a leading pharmaceutical company and global leader in biopharmaceutical contract development and manufacture, announced today that they have entered into a strategic agreement.
Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, has initiated the Phase I clinical trial of sulfatinib (HMPL-012) in the United States.
Japan will support Cambodia, Indonesia, Laos and Viet Nam with $1.6 million in the fight against avian influenza, FAO announced today.
Vasoproliferative ocular diseases are responsible for sight loss in millions of people in the industrialised countries. Many patients do not currently respond to the treatment offered, which targets a specific factor, VEGF. A team of Inserm researchers at the Vision Institute (Inserm/CNRS/Pierre and Marie Curie University), in association with a team from the Yale Cardiovascular Research Center, have demonstrated in an animal model that blocking another protein, Slit2, prevents the pathological blood vessel development that causes these diseases.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dennis Lee Doke, LMFT-S, LPC-S 9128 Autumn Falls Dr, Fort Worth, TX 76118-7765 Ph: (214) 677-6689 | Dennis Lee Doke, LMFT-S, LPC-S 9128 Autumn Falls Dr, Fort Worth, TX 76118-7765 Ph: (214) 677-6689 |
News Archive
BioImagene, the leading provider of innovative digital pathology solutions, today announced the availability of the next generation of its digital pathology solution, VirtuosoTM. A highlight in this version is the ability to share cases in real time, allowing pathologists to collaborate with each other to sign out cases. Virtuoso users can participate in peer reviews, perform second-opinions for difficult cases, and guide residents in the review of cases for education.
Pfenex Inc., an industry leader in protein expression through the Pfenex Expression Technology platform and Boehringer Ingelheim International GmbH, a leading pharmaceutical company and global leader in biopharmaceutical contract development and manufacture, announced today that they have entered into a strategic agreement.
Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, has initiated the Phase I clinical trial of sulfatinib (HMPL-012) in the United States.
Japan will support Cambodia, Indonesia, Laos and Viet Nam with $1.6 million in the fight against avian influenza, FAO announced today.
Vasoproliferative ocular diseases are responsible for sight loss in millions of people in the industrialised countries. Many patients do not currently respond to the treatment offered, which targets a specific factor, VEGF. A team of Inserm researchers at the Vision Institute (Inserm/CNRS/Pierre and Marie Curie University), in association with a team from the Yale Cardiovascular Research Center, have demonstrated in an animal model that blocking another protein, Slit2, prevents the pathological blood vessel development that causes these diseases.
› Verified 3 days ago
Dr. Eunice L Jenkins, PHD Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 4500 Mercantile Plaza Dr Ste 300, Fort Worth, TX 76137 Phone: 214-273-4024 | |
Violeta Dimitrova Kadieva, PH. D. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 3110 E Rosedale St, Fort Worth, TX 76105 Phone: 817-531-4232 | |
Paulina Natalia Guzzardo, PHD, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1650 W Rosedale St Ste 305, Fort Worth, TX 76104 Phone: 817-381-5122 | |
David W. Farmer, LPC, LMFT Couples Therapy Medicare: Medicare Enrolled Practice Location: 855 Montgomery St, Fort Worth, TX 76107 Phone: 817-735-5051 Fax: 817-735-0651 | |
Nicole Van Ness, PSYD Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 604 Candlewood Rd, Fort Worth, TX 76103 Phone: 858-356-7444 | |
Mrs. Zully Schultz, LMFT-A Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 1509b S. University Dr., Suite 212, Fort Worth, TX 76107 Phone: 817-885-7777 | |
Carolyn V Becker, MS, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 4700 Keller Hicks Rd, Fort Worth, TX 76244 Phone: 817-349-3898 |